The relationship between mucosal immunoresponse and clinical outcome in patients with recurrent upper respiratory tract infections treated with a mechanical bacterial lysate

Journal of Biological Regulators and Homeostatic Agents

Volumn 25, Issue 3, 2011, Pages 477-485

  Braido, F ^a   Schenone, G ^b   Pallestrini, E ^b   Reggiardo, G ^c   Cangemi, G ^d   Canonica, G W ^a   Melioli, Giovanni ^d  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Biometry Unit   (Italy)

^d G GASLINI INSTITUTE   (Italy)

Author keywords

Locoregional immunoresponse; Polyvalent mechanical bacterial lysate; Recurrent upper respiratory tract infections

Indexed keywords

ANTIBODY; BACTERIUM LYSATE; BACTERIUM LYSATE ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; BACTERICIDAL ACTIVITY; CHRONIC RHINITIS; CHRONIC SINUSITIS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MECHANISM; DRUG TREATMENT FAILURE; FEMALE; HUMAN; HUMAN CELL; LARYNGITIS; MALE; MUCOSAL IMMUNITY; MULTIPLE CYCLE TREATMENT; NONHUMAN; OPSONIZATION; PHARYNGITIS; PHARYNGOLARYNGITIS; PHARYNGOTONSILITIS; PHENOTYPE; PROSPECTIVE STUDY; RECURRENT INFECTION; SALIVA; SEROLOGY; SINUSITIS; STAPHYLOCOCCUS AUREUS; TH0 CELL; TH1 CELL; TH2 CELL; TONSILLITIS; TREATMENT OUTCOME; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; BACTERIA; COMPLEX MIXTURES; FEMALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULINS; IMMUNOTHERAPY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; SALIVA; TH1 CELLS; TH2 CELLS;

BACTERIA (MICROORGANISMS);

EID: 80755142774     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kalkman PM, Fokkens WJ, de Wit HJ, et al. A hampered chemoattractant- induced cytoskeletal rearrangement in granulocytes of patients with unexplained severe chronic and relapsing infections of the upper and lower airways. In vitro restoration by G-CSF exposure. Clin Exp Immunol 2002; 127:115-22. (Pubitemid 34155466)
2. Kowalska M, Kowalska H, Zawadzka-Glos L, Debska M, Szerszeń E, Chmielik M, Wasik M. Dysfunction of peripheral blood granulocyte oxidative metabolism in children with recurrent upper respiratory tract infections. Int J Pediatr Otorhinolaryngol 2003; 67:365-71. (Pubitemid 36349368)
3. Rossi ME, Marranci S, De Marco A, Lega L, Minutello MA, Azzari C, Resti M, Vierucci A. Reduced natural killer function in children with recurrent respiratory tract infections. Pediatr Med Chir 1993; 15:1-4.
4. Fahlman MM, Engels HJ. Mucosal IgA and URTI in American college football players: a year longitudinal study. Med Sci Sports Exerc 2005; 37:374-80. (Pubitemid 40354445)
5. Nakamura C, Akimoto T, Suzuki S, Kono I. Daily changes of salivary secretory immunoglobulin A and appearance of upper respiratory symptoms during physical training. J Sports Med Phys Fitness 2006; 46:152-7. (Pubitemid 43742463)
6. Rossi GA, Peri C, Raynal ME, Defilippi AC, Risso FM, Schenone G, Pallestrini E, Melioli G. Naturally occurring immune response against bacteria commonly involved in upper respiratory tract infections: analysis of the antigen-specific salivary IgA levels. Immunol Lett 2003; 86:85-91. (Pubitemid 36205042)
7. Morandi B, Agazzi A, D'Agostino A, Antonini F, Costa G, Sabatini F, Ferlazzo G, Melioli G. A mixture of bacterial mechanical lysates is more efficient than single strain lysate and of bacterial-derived soluble products for the induction of an activating phenotype in human dendritic cells. Immunol Lett 2011; 138:86-91.
8. Lanzilli G, Falchetti R, Cottarelli A, Macchi A, Ungheri D, Fuggetta MP. In vivo effect of an immunostimulating bacterial lysate on human B lymphocytes. Int J Immunopathol Pharmacol 2006; 19:551-9. (Pubitemid 44580528)
9. Rosaschino F, Cattaneo L. Strategies for optimizing compliance of paediatric patients for seasonal antibacterial vaccination with sublingually administered Polyvalent Mechanical Bacterial Lysates (PMBL). Acta Biomed 2004; 75:171-8.
10. Tricarico D, Varricchio A, D'Ambrosio S, Ascione E, Motta G. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial. Arzneimittelforschung 2004; 54:57-63. (Pubitemid 38147096)
11. Macchi A, Vecchia LD. Open comparative, randomized controlled clinical study of a new immunostimulating bacterial lysate in the prophylaxis of upper respiratory tract infections. Arzneimittelforschung. 2005; 55:276-81. (Pubitemid 40780381)
12. Braido F, Tarantini F, Ghiglione V, Melioli G, Canonica GW.Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections. Int J Chron Obstruct Pulmon Dis 2007; 2:335-45. (Pubitemid 350110907)
13. Stevens TL, Bossie A, Sanders VM,Fernandez-Botran R, Coffman RL, Mosmann TR, Vitetta ES. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 1988; 334:255-8.
14. Frumento G, Ottonello L, Bertolotto M, Franchello S, Melioli G, Dallegri F. Spontaneous apoptosis in neutrophils is associated with downregulation of HLA Class I and is prevented by ligation of Class I. J Leukoc Biol 2000; 68:873-80.
15. Zelle-Rieser C, Ramoner R, Bartsch G, Thurnher M. A clinically approved oral vaccine against pneumotropic bacteria induces the terminal maturation of CD83+ immunostimulatory dendritic cells. Immunol Lett 2001; 76:63-7. (Pubitemid 32166913)